What went wrong (a lot), what went right (vaccine development and distribution plan), and what lessons must we learn from the federal government's response to the COVID-19 global pandemic.
What are the biggest risks looming for the supply chain in the first quarter of 2021? Zach Zacharia discusses the latest Lehigh Business Supply Chain Risk Management Index report.
The old saying that you don't get a second chance to make a first impression is especially true when it comes to vaccines, according to a study by two College of Business economics researchers. If the first opinion people form about a new COVID-19 vaccine is negative, it will be difficult to rebuild public trust.
Science has long concluded there is no link between vaccines and autism. So why do some people refuse to believe it? Confirmatory bias helps explain.